<DOC>
	<DOCNO>NCT00407186</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety combine chemotherapy radiotherapy ( comparison chemotherapy alone ) adjuvant treatment surgery gastric cancer . Prior surgery patient receive neo-adjuvant chemotherapy well .</brief_summary>
	<brief_title>Randomized Phase III Trial Adjuvant Chemotherapy Chemoradiotherapy Resectable Gastric Cancer ( CRITICS )</brief_title>
	<detailed_description>The mainstay curative treatment gastric cancer radical surgical dissection . Because patient Western world present advance stage long term survival find 25 % , local recurrence part treatment failure 80 % case . Studies examine role extend lymph node dissection ( D1 vs. D2 ) , adjuvant radiotherapy adjuvant chemotherapy result clinical relevant improvement survival . In 2001 result South West Oncology group ( SWOG ) trial randomize surgery surgery chemoradiotherapy publish . This trial , hamper suboptimal surgery ( less D1 majority patient ) radiotherapy ( 2D radiotherapy ; 35 % protocol deviation ) show absolute increase median survival 9 month . More recently result MAGIC study , randomize surgery surgery plus 6 perioperative course ECF chemotherapy , present . This regimen result absolute 5-year survival benefit 13 % 10 % high resectability rate . This phase III prospectively randomize study investigate whether chemoradiotherapy ( 45 Gy 5 week daily cisplatin capecitabine ) preoperative chemotherapy ( 3x ECC ( epirubicin , cisplatin , capecitabine ) ) adequate ( D1+ ) surgery lead improved survival comparison postoperative chemotherapy ( 3x ECC ) . Furthermore , toxicity treatment regimen explore .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>IbIVa ( distant metastasis ) gastric cancer ( histologically proven ) ; tumor bulk stomach WHO &lt; 2 Age â‰¥18 yr Operable gastric cancer No prior abdominal radiotherapy chemotherapy Tumornegative laparoscopy CT suggest peritoneal carcinomatosis Start treatment within 10 work day registration Written inform consent T1N0 disease ( endoscopic ultrasound ) Distant metastases Inoperable patient ; due technical surgeryrelated factor general condition Previous malignancy , except adequately treat nonmelanoma skin cancer insitu cancer cervix uterus . Solitary function kidney within radiation field Major surgery within 4 week prior study treatment start , lack complete recovery effect major surgery Uncontrolled ( bacterial ) infection Significant cardiac disorder Continuous use immunosuppressive agent Concurrent use antiviral agent sorivudine chemically related analogue Hearing loss &gt; CTC grade 1 Neurotoxicity &gt; CTC grade 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>CRITICS</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>surgery</keyword>
	<keyword>adjuvant</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>chemoradiotherapy</keyword>
	<keyword>capecitabine</keyword>
	<keyword>cisplatin</keyword>
	<keyword>epirubicin</keyword>
</DOC>